Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

COSMO PHARMACEUTICALS N.V.

(A2AJ68)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über COSMO PHARMACEUTICALS N.V.
04.10.CASSIOPEA : Cosmo rapatrie sa filiale, faute de repreneur
04.10.BOURSE ZURICH : Wall Street trébuche, le SMI résiste
04.10.COSMO PHARMACEUTICALS N : Casa farmaceutica Cosmo concorda offerta di acquisizione per Cas..
04.10.BOURSE ZURICH : les investisseurs hésitants à l'approche de la mi-journée
04.10.BOURSE ZURICH : les investisseurs se montrent hésitants à l'ouverture
04.10.BOURSE ZURICH : ouverture attendue sans véritable direction
04.10.COSMO PHARMACEUTICALS N : Initiates Public Exchange Offer For Cassiopea
04.10.Cosmo Pharmaceuticals lance une offre publique d'échange pour racheter Cassiopea
04.10.Cosmo pharmaceuticals n.v. launches public exchange offer to acquire cassiopea s.p.a.
04.10.Cosmo pharmaceuticals n.v. launches -2-
04.10.Les valeurs à suivre à Paris et en Europe (actualisé)
30.07.Cosmo creuse ses pertes au premier semestre
30.07.COSMO PHARMACEUTICALS N : Logs Widened H1 Loss On Higher Expenses
30.07.EQS-ADHOC : Cosmo Half-Year Report 2021
30.07.Cosmo Pharmaceuticals N.V. Reports Earnings Results for the Half Year Ended June 30, 20..
29.07.EQS-ADHOC : Cassiopea Announces Results for First Half of 2021
26.07.CASSIOPEA S P A : Enters License, Supply Deals for Acne Treatment in North America
26.07.EQS-ADHOC : Cosmo Pharmaceuticals Announces Cassiopea SpA's Signing of License and Supply ..
28.05.EQS-ADHOC : Cosmo Pharmaceuticals' Shareholders approve all Agenda Items at Annual General..
28.05.COSMO PHARMACEUTICALS N : ' Shareholders approve all Agenda Items at Annual General Meetin..
10.05.Principales informations avant-Bourse
10.05.Cosmo Pharmaceuticals annonce un changement au conseil d'administration
10.05.COSMO PHARMACEUTICALS N : announces a change in its board of directors
10.05.Cosmo Pharmaceuticals N.V. Announces Resignation of Hans Christoph Tanner as A Non-Exec..
04.05.Acacia Pharma lost schuldfaciliteit vroegtijdig af
29.04.COSMO PHARMACEUTICALS N : Invitation to Cosmo's GI Genius Q&A session for investors, analy..
21.04.COSMO PHARMACEUTICALS N : Seeks US Approval For GI Genius Endoscopy System
19.04.En bourse, les arbres montent-ils jusqu'au ciel ?
19.04.COSMO PHARMACEUTICALS N : Lists Shares On Frankfurt's Xetra Bourse
19.04.EN DIRECT DES MARCHES : Renault, Faurecia, Korian, Daimler, Tesla, Coinbase, ABM Amro, Juv..
19.04.Cosmo annonce l'intégration de son action sur le Xetra
19.04.COSMO PHARMACEUTICALS N : announces the start of trading of its shares on XETRA
13.04.COSMO PHARMACEUTICALS N : announces FDA approval of GI Genius intelligent endoscopy module..
12.04.COSMO : la FDA homologue le dispositif d'endoscopie intelligent GI Genius
12.04.COSMO PHARMACEUTICALS N : Wins US FDA Nod For New Endoscopy System
12.04.COSMO PHARMACEUTICALS N : announces FDA approval of GI Genius(TM) intelligent endoscopy mo..
12.04.COSMO PHARMACEUTICALS N : announces FDA approval of GI Genius(TM) intelligent endoscopy mo..
12.04.Cosmo Pharmaceuticals NV Announces FDA Approval of GI Genius Intelligent Endoscopy Modu..
29.03.COSMO PHARMACEUTICALS N : Full-year report 2020
26.03.Cosmo Pharmaceuticals N.V. Provides Earnings Guidance for the Year 2021
26.03.Cosmo a sensiblement amenuisé ses pertes en 2020
26.03.Cosmo Pharmaceuticals N.V. Reports Earnings Results for the Full Year Ended December 31..
26.03.COSMO PHARMACEUTICALS N : FY20 Loss Shrinks On Return to Operating Profit, Lower Expenses
26.03.COSMO FULL-YEAR REPORT 2020 : Cosmo returns to operating profit
26.03.EQS-ADHOC : Cosmo Full-Year Report 2020: Cosmo -2-
26.03.EQS-ADHOC : Cosmo Full-Year Report 2020: Cosmo returns to operating profit
26.03.COSMO FULL-YEAR REPORT 2020 : Cosmo returns to operating profit
19.02.COSMO PHARMACEUTICALS N : RedHill Biopharma Strengthens Partnership with Cosmo Pharmaceuti..
18.02.COSMO PHARMACEUTICALS N : Adds Three Products to Manufacturing Deal With RedHill Biopharma
18.02.Cosmo confirme la production de trois traitements de Redhill
18.02.Cosmo Pharmaceuticals Strengthens Partnership with RedHill Biopharma with Manufacturing..
08.02.COSMO PHARMACEUTICALS N : announces license of Lumeblue EU rights to Alfasigma
05.02.Alfasigma Spa Enters into Licensing Agreement to Distribute Lumeblue™ in the Eu with Co..
05.02.COSMO PHARMACEUTICALS N : Licenses EU Rights for Lumeblue to Alfasigma
05.02.Cosmo confie les droits européens pour Lumeblue à Alfasigma
05.02.Cosmo announces license of Lumeblue™ (Methylene Blue MMX) EU rights to Alfasigma
05.02.Cosmo Pharmaceuticals NV Announces License of Lumeblue EU Rights to Alfasigma
11.01.COSMO PHARMACEUTICALS N : Achieves Statistical Significance For Phase II Trials Of Irritab..
11.01.COSMO : succès d'étape avec Ryfamycin contre le côlon irritable
11.01.Cosmo announces successful outcome of Rifamycin 600mg Phase II trial in IBS-D
11.01.Cosmo Pharmaceuticals N.V Announces Successful Outcome of Rifamycin 600Mg Phase II tria..
2020COSMO PHARMACEUTICALS N : Announces Senior Leadership Change
2020COSMO PHARMACEUTICALS N : COO to Retire
2020COSMO : le responsable des opérations Giuseppe Cipriano prend sa retraite
2020Cosmo Pharmaceuticals Announces Senior Leadership Change
2020Cosmo Pharmaceuticals N.V. Announces Executive Changes
2020COSMO PHARMACEUTICALS N : Acacia Pharma Announces Amendment of its Investment Agreement wi..
2020COSMO PHARMACEUTICALS N : to Receive $6 Million Milestone Payment from Acacia on First US ..
2020Cosmo ajuste son contrat d'investissement avec Acacia
2020Cosmo Pharmaceuticals Announces Amendment of its Investment Agreement with Acacia
2020Cosmo Pharmaceuticals Announces Amendment of Its Investment Agreement with Acacia
2020COSMO PHARMACEUTICALS N : announces licence of Lumeblue China rights to China Medical Syst..
2020COSMO PHARMACEUTICALS N : Signs License Deal in China for Colonoscopy Lesions Drug Lumeblu..
2020Cosmo cède les droits de licence pour Lumeblue en Chine à CMS
2020Cosmo Pharmaceuticals announces licence of Lumeblue™ (Methylene Blue MMX) China r..
1  2  3  4  5  6Weiter
Anstehende Termine für COSMO PHARMACEUTICALS N.V.